Patient-friendly options could upend plaque psoriasis market

Market research from industry commentator GlobalData finds that new creams and tablets are on the way in plaque psoriasis (PsO).

These candidates will offer people a favorable mode of administration compared to existing injectable biologics, the current leading class of therapy for the incurable condition.

High levels of innovation in the pipeline for the autoimmune disorder could lead to “a flood of topical creams and tablets,” the groups said.